4//SEC Filing
McDonough John 4
Accession 0000899243-21-026529
CIK 0001492674other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 2:56 PM ET
Size
9.3 KB
Accession
0000899243-21-026529
Insider Transaction Report
Form 4
McDonough John
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2021-06-25+45,454→ 534,568 total - Exercise/Conversion
Restricted Stock Units
2021-06-25−45,454→ 45,454 total→ Common Stock (45,454 underlying) - Award
Restricted Stock Units
2021-06-25+81,967→ 81,967 total→ Common Stock (81,967 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]On August 6, 2020 the reporting person was granted 45,454 restricted stock units that vested on June 25, 2021.
- [F3]The restricted stock units vest in one installment on the earlier of (i) June 25, 2022 and (ii) the date of the next annual meeting of stockholders.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001615937
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 2:56 PM ET
- Size
- 9.3 KB